Skip to main content

Consumer

By Jessica Hagen | 03:19 pm | June 23, 2025
The vision-restoring device will be implanted in humans within six to 12 months, following a successful monkey implantation that has remained active for three years, Musk said.
HIMSS25
By HIMSS TV | 11:30 am | June 23, 2025
Dr. Sarah Hoffe, interim GI oncology chair at Moffitt Cancer Center, says telemedicine platforms and other technologies help ease nurse burnout, boost patient adherence and enable focused, personalized patient connections.
By Jessica Hagen | 02:02 pm | June 18, 2025
The partnership will allow Oura Ring wearers to share their biometric data with the virtual women's health company's care teams.
By HIMSS TV | 11:41 am | June 16, 2025
Anil Soni, CEO of the WHO Foundation, discusses a $3.6 million fundraising initiative, enhanced by a dollar-for-dollar match, to protect the Global Measles and Rubella Laboratory Network, working to control and eliminate both diseases.
HIMSS25
By HIMSS TV | 05:52 pm | June 11, 2025
Rahul Mahadevan, founder and CEO of The WiTT Group, discusses the company's platform, which empowers patients to reach out for their non-clinical needs and gives health systems visibility into patients' biggest challenges.
By HIMSS TV | 11:53 am | June 11, 2025
Millie founder and CEO Anu Sharma discusses reasons why one-third of the U.S. is considered a "maternity care desert" and what can be done.  
By Jessica Hagen | 09:00 am | June 09, 2025
The partners will develop and clinically validate an AI tool that integrates into EHRs to accelerate the diagnosis of hypophosphatasia, a rare genetic bone disorder.
By Jessica Hagen | 01:00 pm | June 04, 2025
The company aims to create a tech-driven, interoperable healthcare system that improves the patient experience while streamlining communication across brands.
By Jessica Hagen | 12:47 pm | June 03, 2025
The healthcare engagement company, which focuses on vulnerable populations, acquired the food delivery company, thanks to a $47.5 million investment.
By Jessica Hagen | 12:03 pm | June 03, 2025
Jayme Strauss, chief commercial and clinical officer at Precision Neuroscience, joined MobiHealthNews to discuss the company's brain-computer interface aimed at allowing individuals to control digital devices using their thoughts.